Key result
ACE inhibitors, beta-blockers, and biventricular pacing effectively prevent heart failure and recurrent congestion.
Why the study?
Efforts to prevent heart failure are not generally well studied despite its sizeable health burden.
Prevention strategies for heart failure remain understudied; leaves open the role of expanded ACE-inhibitor use and device therapies pending prospective trials.
Heart failure carries a sizeable health burden. Efforts to prevent this condition are not generally well studied. Most of the interventions that have demonstrated benefit address cardiac risk factors such as hypertension and hyperlipidemia. The results of the HOPE study have recently expanded the indications for angiotensin converting enzyme inhibitors in the prevention of heart failure. Once heart failure occurs, a variety of interventions can prevent recurrent episodes of congestion. Biventricular pacing, left ventricular assist devices, and disease-specific management clinics join more standard medical therapies such as angiotensin converting enzyme inhibitors, beta-blockers, diuretics, digoxin, and spironolactone in improving outcomes for patients with this disorder.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2002) conducted a review in Heart failure. Heart failure prevention strategies was evaluated. Various interventions, including ACE inhibitors, beta-blockers, and biventricular pacing, are highlighted as effective strategies for preventing heart failure and recurrent congestion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: